Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppe Derosa

Showing results (151-160 of 250) with videos related to

Pageof 25
Sort By:
Internal Medicine (Tokyo, Japan)|October 4, 2013
Variations in inflammatory biomarkers following the addition of sitagliptin in patients with type 2 diabetes not controlled with metforminGiuseppe Derosa, Anna Carbone, Angela D'Angelo, et al.
Expert Opinion on Drug Safety|July 3, 2013
Evaluation of safety and efficacy of a fixed olmesartan/amlodipine combination therapy compared to single monotherapiesGiuseppe Derosa, Arrigo Francesco Giuseppe Cicero, Anna Carbone, et al.
European Journal of Clinical Pharmacology|August 10, 2006
Effects of amlodipine-atorvastatin combination on inflammation markers and insulin sensitivity in normocholesterolemic obese hypertensive patientsRoberto Fogari, Paola Preti, Annalisa Zoppi, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|December 24, 2010
Fibrinolysis and insulin sensitivity in imidapril and candesartan (FISIC study) recipients with hypertensionRoberto Fogari, Annalisa Zoppi, Sibilla A T Salvadeo, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|April 9, 2010
Omega 3 polyunsaturated fatty acids supplementation and blood pressure levels in hypertriglyceridemic patients with untreated normal-high blood pressure and with or without metabolic syndrome: a retrospective studyArrigo F G Cicero, Giuseppe Derosa, Valentina Di Gregori, et al.
Current Pharmaceutical Design|October 11, 2016
Effect of Sibutramine on Plasma C-Reactive Protein, Leptin and Adipon ectin Concentrations: A Systematic Review and Meta-Analysis of Randomized Contr olled TrialsAntonio De Vincentis, Claudio Pedone, Umberto Vespasiani-Gentilucci, et al.
European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology|September 11, 2009
Effect of a sequential training programme on inflammatory, prothrombotic and vascular remodelling biomarkers in hypertensive overweight patients with or without metabolic syndromeArrigo F G Cicero, Giuseppe Derosa, Marilisa Bove, et al.
Internal Medicine (Tokyo, Japan)|November 5, 2008
Effect of valsartan addition to amlodipine on insulin sensitivity in overweight-obese hypertensive patientsRoberto Fogari, Paola Preti, Annalisa Zoppi, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|September 4, 2013
Results from a 12 months, randomized, clinical trial comparing an olmesartan/amlodipine single pill combination to olmesartan and amlodipine monotherapies on blood pressure and inflammationGiuseppe Derosa, Arrigo F G Cicero, Anna Carbone, et al.
Journal of the American Society of Hypertension : JASH|January 17, 2013
Variation of some inflammatory markers in hypertensive patients after 1 year of olmesartan/amlodipine single-pill combination compared with olmesartan or amlodipine monotherapiesGiuseppe Derosa, Arrigo F G Cicero, Anna Carbone, et al.
Pageof 25

Showing results (151-160 of 250) with videos related to

Sort By:
Pageof 25
Internal Medicine (Tokyo, Japan)|October 4, 2013
Variations in inflammatory biomarkers following the addition of sitagliptin in patients with type 2 diabetes not controlled with metforminGiuseppe Derosa, Anna Carbone, Angela D'Angelo, et al.
Expert Opinion on Drug Safety|July 3, 2013
Evaluation of safety and efficacy of a fixed olmesartan/amlodipine combination therapy compared to single monotherapiesGiuseppe Derosa, Arrigo Francesco Giuseppe Cicero, Anna Carbone, et al.
European Journal of Clinical Pharmacology|August 10, 2006
Effects of amlodipine-atorvastatin combination on inflammation markers and insulin sensitivity in normocholesterolemic obese hypertensive patientsRoberto Fogari, Paola Preti, Annalisa Zoppi, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|December 24, 2010
Fibrinolysis and insulin sensitivity in imidapril and candesartan (FISIC study) recipients with hypertensionRoberto Fogari, Annalisa Zoppi, Sibilla A T Salvadeo, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|April 9, 2010
Omega 3 polyunsaturated fatty acids supplementation and blood pressure levels in hypertriglyceridemic patients with untreated normal-high blood pressure and with or without metabolic syndrome: a retrospective studyArrigo F G Cicero, Giuseppe Derosa, Valentina Di Gregori, et al.
Current Pharmaceutical Design|October 11, 2016
Effect of Sibutramine on Plasma C-Reactive Protein, Leptin and Adipon ectin Concentrations: A Systematic Review and Meta-Analysis of Randomized Contr olled TrialsAntonio De Vincentis, Claudio Pedone, Umberto Vespasiani-Gentilucci, et al.
European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology|September 11, 2009
Effect of a sequential training programme on inflammatory, prothrombotic and vascular remodelling biomarkers in hypertensive overweight patients with or without metabolic syndromeArrigo F G Cicero, Giuseppe Derosa, Marilisa Bove, et al.
Internal Medicine (Tokyo, Japan)|November 5, 2008
Effect of valsartan addition to amlodipine on insulin sensitivity in overweight-obese hypertensive patientsRoberto Fogari, Paola Preti, Annalisa Zoppi, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|September 4, 2013
Results from a 12 months, randomized, clinical trial comparing an olmesartan/amlodipine single pill combination to olmesartan and amlodipine monotherapies on blood pressure and inflammationGiuseppe Derosa, Arrigo F G Cicero, Anna Carbone, et al.
Journal of the American Society of Hypertension : JASH|January 17, 2013
Variation of some inflammatory markers in hypertensive patients after 1 year of olmesartan/amlodipine single-pill combination compared with olmesartan or amlodipine monotherapiesGiuseppe Derosa, Arrigo F G Cicero, Anna Carbone, et al.
Pageof 25